Clinical Trial Update: A Study to Assess Efficacy, Safety and Pharmacokinetics of a Tacrolimus New Oral Formulation (MR4) in BMT Recipients [Phase 2]

View source ↗

Summary

Completion of a Phase 2 study evaluating the efficacy, safety, and pharmacokinetics of a new oral tacrolimus formulation (MR4) in bone marrow transplant recipie…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graft-versus-host Disease

Drugs mentioned

• Tacrolimus MR4 (Tacrolimus)

Snippet

Sponsor: Astellas Pharma Inc | Conditions: Bone Marrow Transplantation, Graft Versus Host Disease | Phase 2 | Status: COMPLETED